Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ANAGRELIDE HCL 0.5 MG CAPSULE

Anagrelide
$0.7265per EA

Strength

.5 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135031212

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ANAGRELIDE HYDROCHLORIDE ANHYDROUS

Approval Type

Generic (ANDA)

FDA Application

ANDA076683

On Market Since

4/18/2005

Pharmacological Classes

Decreased Platelet Production
Phosphodiesterase 3 Inhibitors
Platelet-reducing Agent

Price History

1W

0.0%

1M

-0.5%

3M

+0.1%

6M

+1.7%

1Y

-2.3%

3Y

N/A

5Y

N/A

All

-4.5%

Generic Alternatives

1 alternative • Same active ingredient

ANAGRELIDE HCL 0.5 MG CAPSULE
Generic
70954087910•ANI Pharmaceuticals, Inc.
$0.7265

Related Drugs

Same classification

CILOSTAZOL 50 MG TABLET
Generic
00093206506•Teva Pharmaceuticals USA Inc.
$0.1162
per EA
CILOSTAZOL 50 MG TABLET
Generic
50268017615•AvPAK
$0.1162
per EA
CILOSTAZOL 50 MG TABLET
Generic
60505252101•Apotex Corp.
$0.1162
per EA
CILOSTAZOL 50 MG TABLET
Generic
70436015606•Slate Run Pharmaceuticals LLC
$0.1162
per EA
CILOSTAZOL 100 MG TABLET
Generic
00093206406•Teva Pharmaceuticals USA Inc.
$0.1287
per EA
CILOSTAZOL 100 MG TABLET
Generic
00093206450•Teva Pharmaceuticals USA Inc.
$0.1287
per EA
CILOSTAZOL 100 MG TABLET
Generic
50268017715•AvPAK
$0.1287
per EA
CILOSTAZOL 100 MG TABLET
Generic
60505252201•Apotex Corp.
$0.1287
per EA
CILOSTAZOL 100 MG TABLET
Generic
70436015706•Slate Run Pharmaceuticals LLC
$0.1287
per EA
ANAGRELIDE HCL 0.5 MG CAPSULE
Generic
13668045301•Torrent Pharmaceuticals Limited
$0.7265
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy